Eu
Eutilex
Seoul KRFounded 201050 employees
Private CapbiotechPrivateOncology
Platform: 4-1BB BiTE
Market Cap
N/A
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Zoribrutinib | EUT-7180 | Phase 2/3 | 1 | WRN | Huntington'sUrothelial Ca | ||
| Ivovorutinib | EUT-3628 | NDA/BLA | 2 | CD38 | MCC |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (3)